Vertex Pharmaceuticals (VRTX) Exchange Rate Effect (2009 - 2026)

Vertex Pharmaceuticals' Exchange Rate Effect history runs 18 years deep, the most recent figure standing at -$40.3 million for Q1 2026.

• In Q1 2026, Exchange Rate Effect fell 232.13% year-over-year to -$40.3 million; the TTM figure through Mar 2026 stood at $20.1 million (up 474.29% YoY), while the FY2025 annual figure was $90.9 million, up 313.38% from the prior year.
• Exchange Rate Effect was -$40.3 million for Q1 2026 at Vertex Pharmaceuticals, down from $7.3 million in the prior quarter.
• In the past five years, Exchange Rate Effect ranged from a high of $57.2 million in Q2 2025 to a low of -$47.3 million in Q4 2024.
• Historically, Exchange Rate Effect has averaged $335294.1 across 5 years, with a median of -$2.5 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Exchange Rate Effect sank 747.5% in 2022, then jumped 2388.0% in 2025.
• A 5-year view of Exchange Rate Effect shows it stood at $40.8 million in 2022, then slumped by 32.84% to $27.4 million in 2023, then sank by 272.63% to -$47.3 million in 2024, then jumped by 115.43% to $7.3 million in 2025, then sank by 652.05% to -$40.3 million in 2026.
• The last three Exchange Rate Effect figures came in at -$40.3 million (Q1 2026), $7.3 million (Q4 2025), and -$4.1 million (Q3 2025), per Business Quant data.